NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
03/31/2025
Back to search
Official data from USPTO
CLINICAL AND SAFETY EVALUATION (CASE RX)
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CLINICAL AND SAFETY EVALUATION (CASE RX)
ST13
US500000088066824Class
36, 44
Filing
88066824
Registration
5922041
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
47
Latest update
04/01/2025
Trademark type
Word
Nice classes
36, 44
Filing date
08/06/2018
Registration date
11/26/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/31/2025
Last transaction
04/01/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
07/01/2019
First use in commerce
07/01/2019
Drawing code
4
Owner type
03
Owner location
St. Louis, MO
Examiner
LAMONT, MIAH
Current location
FILE DESTROYED
Holders and representatives
Holders
Express Scripts Strategic Development, Inc.
Representatives
Troy E. Larson
Technical classification
Nice Classes
Class 36Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 36
Pharmacy benefit analysis servicestrackingmonitoringassessing and analyzing information regarding prescription drug use and healthcare treatmentall to identify potential cost savings; drug utilization review services for pharmacy benefit management clients; pharmaceutical cost management services for pharmacy benefit management clients; reporting information in the field of pharmacy benefit managementpharmaceutical use and healthcare useall to identify potential cost savings; safety management effortstrackingmonitoringreportingassessing and analyzing information and statistics regarding patient prescription drug use and healthcare habitsall to identify potential cost savings
Class 44
Providing medical informationreporting and analysis in the fields of healthcare and pharmaceuticals and workers compensation; providing information in the field of healthcare as provided to pharmacy benefit management services clientsconsultants and brokersto improve clinical outcomes for injured workers; providing information in the field of healthcare treatment; care managementtrackingmonitoringreportingassessing and analyzing information and statistics regarding patient prescription drug use and healthcare habitsall for improved clinical outcomes
Publications
History of USPTO decisions and trademark events.
47 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
03/31/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/31/2025
E815
TEAS SECTION 8 & 15 RECEIVED
12/12/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
11/26/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/25/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/25/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/25/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
11/26/2019
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10/22/2019
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/21/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
10/21/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/21/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
10/21/2019
SNEA
SU-EXAMINER'S AMENDMENT WRITTEN
10/21/2019
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/21/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/21/2019
IUAF
USE AMENDMENT FILED
09/30/2019
EISU
TEAS STATEMENT OF USE RECEIVED
09/30/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/04/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/04/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04/30/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/05/2019
PUBO
PUBLISHED FOR OPPOSITION
03/05/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/13/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/28/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
01/28/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/28/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
01/28/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/28/2019
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
01/28/2019
PBER
WITHDRAWN FROM PUB - EXAMINING ATTORNEY REQUEST
01/28/2019
ALIE
ASSIGNED TO LIE
01/24/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/09/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
01/09/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/09/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
01/09/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/09/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/19/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/18/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/18/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/16/2018
GNRT
NON-FINAL ACTION E-MAILED
11/16/2018
CNRT
NON-FINAL ACTION WRITTEN
11/16/2018
DOCK
ASSIGNED TO EXAMINER
11/09/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/10/2018
NWAP
NEW APPLICATION ENTERED
08/09/2018
Continuous trademark protection
Get notified about every new filing that threatens CLINICAL AND SAFETY EVALUATION (CASE RX) or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.